Quarterly report [Sections 13 or 15(d)]

Statements of Operations (Unaudited)

v3.25.3
Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses:        
Research and development $ 2,964 $ 3,045 $ 6,871 $ 14,726
General and administrative 4,378 3,206 15,422 8,130
Total operating expenses 7,342 6,251 22,293 22,856
Loss from operations (7,342) (6,251) (22,293) (22,856)
Other income (expenses):        
Interest income 279 416 661 947
Interest expense (15) (15) (44) (51)
Change in fair value of warrant liability 1,067 1,754 9,789 6,756
Total other income (expenses) 1,331 2,155 10,406 7,652
Net loss (6,011) (4,096) (11,887) (15,204)
Dividend to Series B-1 preferred stockholders (1,095)
Net loss attributable to common stockholders $ (6,011) $ (4,096) $ (11,887) $ (16,299)
Net loss per share attributable to common stockholders, basic (in Dollars per share) $ (0.33) $ (0.46) $ (0.85) $ (3.01)
Net loss per share attributable to common stockholders, diluted (in Dollars per share) $ (0.33) $ (0.46) $ (0.85) $ (3.01)
Weighted-average shares outstanding used in computing net loss per share, basic (in Shares) 18,065,389 8,894,321 14,038,696 5,407,370
Weighted-average shares outstanding used in computing net loss per share,diluted (in Shares) 18,065,389 8,894,321 14,038,696 5,407,370